Showing results (1-10 of 2,454) with videos related to

Sort By:
Pageof 246
Statistics in Medicine|November 6, 2007
Evaluating a surrogate endpoint at three levels, with application to vaccine developmentPeter B Gilbert, Li Qin, Steven G Self
The Journal of Infectious Diseases|October 9, 2007
A framework for assessing immunological correlates of protection in vaccine trialsLi Qin, Peter B Gilbert, Lawrence Corey, et al.
Statistical Methods in Medical Research|April 8, 2004
Endpoints in vaccine trialsMichael G Hudgens, Peter B Gilbert, Steven G Self
Plos Computational Biology|June 23, 2006
On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trialsW David Wick, Peter B Gilbert, Steven G Self
Statistics in Biopharmaceutical Research|March 25, 2014
Statistical approaches to analyzing HIV-1 neutralizing antibody assay dataXuesong Yu, Peter B Gilbert, Catarina E Hioe, et al.
Contemporary Clinical Trials|January 24, 2006
Statistical evaluation of HIV vaccines in early clinical trialsZoe Moodie, A J Rossini, Michael G Hudgens, et al.
The Journal of Infectious Diseases|July 11, 2003
What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trialsPeter B Gilbert, Victor G DeGruttola, Michael G Hudgens, et al.
The Journal of Infectious Diseases|July 14, 2009
Power to detect the effects of HIV vaccination in repeated low-dose challenge experimentsMichael G Hudgens, Peter B Gilbert, John R Mascola, et al.
The Annals of Applied Statistics|December 17, 2008
ASSESSING SURROGATE ENDPOINTS IN VACCINE TRIALS WITH CASE-COHORT SAMPLING AND THE COX MODELLi Qin, Peter B Gilbert, Dean Follmann, et al.
Vaccine|August 8, 2006
Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluationFusheng Li, Uma Malhotra, Peter B Gilbert, et al.
Pageof 246